By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Galapagos NV 

Industriepark Mechelen Noord I, Zone L
Generaal De Wittelaan 11 A
Mechelen    B-2800  Belgium
Phone: 32-15-34-29-00 Fax: 32-15-34-29-01



Company News
Galapagos NV (GLPG.BR) Reports High Participation Rate In Long Term Extension Study With GLPG0634 In RA Patients 9/18/2014 10:27:18 AM
Galapagos NV (GLPG.BR) Cash Position Of €232 M Provides Solid Basis For R&D Pipeline Investment 8/8/2014 9:11:12 AM
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Abandon Joint Drug Project Due To Adverse Effects 8/8/2014 6:12:19 AM
Galapagos NV (GLPG.BR) Receives Milestone In Osteoarthritis Alliance With Servier 8/5/2014 8:52:29 AM
Galapagos NV (GLPG.BR) Creates New Warrant Plan 7/25/2014 2:51:50 PM
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014 8:21:22 AM
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014 7:54:12 AM
Galapagos NV (GLPG.BR) Initiates Phase 1 Study With GLPG1690, Triggering €6.6 M Milestone In The Alliance With Janssen Pharmaceutica N.V. 7/1/2014 9:13:37 AM
Galapagos NV (GLPG.BR) Cystic Fibrosis Program Progresses Towards Therapy For Largest Patient Group 6/17/2014 8:46:04 AM
Galapagos NV (GLPG.BR) To Hold Annual R&D Update On 17 June 2014 In New York 5/12/2014 11:54:15 AM